Radioimmunotherapy using 131I-rituximab in patients with advanced stage B-cell non-Hodgkin’s lymphoma: initial experience

被引：0
|
作者：
Maren Bienert
Ingrid Reisinger
Stefanie Srock
Beatrice I Humplik
Christel Reim
Thomas Kroessin
Norbert Avril
Antonio Pezzutto
Dieter L Munz
机构：
[1] Charité—Universitätsmedizin Berlin,Clinic for Nuclear Medicine
[2] Charité—Universitätsmedizin Berlin,Department of Haematology and Oncology
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2005年 / 32卷
关键词：
Non-Hodgkin’s lymphoma; Radioimmunotherapy; I-rituximab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1225 / 1233
页数：8
相关论文
共 50 条
  • [21] Radioimmunotherapy for patients with relapsed B-cell non-Hodgkin lymphoma
    Witzig, TE
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 48 (Suppl 1) : S91 - S95
  • [22] Radioimmunotherapy for patients with relapsed B-cell non-Hodgkin lymphoma
    Thomas E. Witzig
    Cancer Chemotherapy and Pharmacology, 2001, 48 : S91 - S95
  • [23] Radioimmunotherapy of Non-Hodgkin B-cell Lymphoma: An update
    Cicone, Francesco
    Santo, Giulia
    Bodet-Milin, Caroline
    Cascini, Giuseppe Lucio
    Kraeber-Bodere, Francoise
    Stokke, Caroline
    Kolstad, Arne
    SEMINARS IN NUCLEAR MEDICINE, 2023, 53 (03) : 413 - 425
  • [24] Radioimmunotherapy of newly diagnosed, advanced, low-grade lymphoma with 131I-rituximab:: The initial study
    McQuillan, A. D.
    Macdonald, W. B.
    Leahy, M. F.
    Turner, J. H.
    ANNALS OF ONCOLOGY, 2008, 19 : 207 - 207
  • [25] Radioimmunotherapy with 131I-rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma
    Jang, Yoon Jung
    Lim, Sang Moo
    Lee, Inki
    Byun, Byung Hyun
    Lim, Ilhan
    Kim, Byung Il
    Choi, Chang Woon
    Lee, Seung-Sook
    Suh, Cheolwon
    Yoon, Dok Hyun
    Kim, Inho
    Nam, Seung-Hyun
    Lee, Mark Hong
    Won, Jong Ho
    Kong, Jee Hyun
    Jeong, Seong Hyun
    Oh, Suk Joong
    Park, Keon Woo
    Han, Jae Joon
    Song, Moo-Kon
    Yang, Sung Hyun
    Na, Im Il
    Lee, Hyo-Rak
    Shin, Dong-Yeop
    Kang, Hye Jin
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 (06) : 690 - 696
  • [26] Clinical development of radioimmunotherapy for B-cell non-Hodgkin's lymphoma
    Meredith, Ruby F.
    Knox, Susan J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (02): : S15 - S22
  • [27] INOTUZUMAB OZOGAMICIN IN PATIENTS WITH INDOLENT B-CELL NON-HODGKIN LYMPHOMA REFRACTORY TO RITUXIMAB AND CHEMOTHERAPY OR RADIOIMMUNOTHERAPY
    Goy, A.
    Leach, J.
    Tsai, M.
    Foran, J.
    Forero, A.
    Wagner-Johnston, N.
    Ehmann, C.
    Egyed, M.
    Ando, K.
    Hatake, K.
    Tobinai, K.
    Feldman, T.
    Vandendries, E.
    Volkert, A.
    Wang, S. L.
    Ogura, M.
    HAEMATOLOGICA, 2012, 97 : 324 - 324
  • [28] INOTUZUMAB OZOGAMICIN IN B-CELL NON-HODGKIN'S LYMPHOMA REFRACTORY TO RITUXIMAB plus CHEMOTHERAPY OR RADIOIMMUNOTHERAPY
    Ogura, M.
    Leach, J.
    Egyed, M.
    Ando, K.
    Hatake, K.
    Tobinai, K.
    Feldman, T.
    Hua, S.
    Volkert, A.
    Vandendries, E.
    Goy, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 94 - 94
  • [29] Radioimmunotherapy for indolent non Hodgkin lymphoma with 131I-rituximab in clinical practice:: 8 year single institution experience of 129 consecutive patients
    Leahy, M. F.
    Turner, J. H.
    ANNALS OF ONCOLOGY, 2008, 19 : 87 - 87
  • [30] First-Line Radio-Immunotherapy of Newly Diagnosed, Advanced Follicular Non-Hodgkin Lymphoma with 131I-Rituximab: The INITIAL Study
    McQuillan, Andrew D.
    Macdonald, William B. G.
    Leahy, Michael F.
    Turner, J. Harvey
    BLOOD, 2011, 118 (21) : 1589 - 1589
12345